Cargando…

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease

OBJECTIVE: To evaluate thyroid‐stimulating immunoglobulin (TSI) and thyrotropin receptor antibodies (TRAb) diagnostic performance for Graves' disease (GD) and determine clinical cut‐off value for diagnosing GD. METHODS: Of 1369 retrospectively enrolled subjects, 1364 had a definitive diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Shiji, Shao, Wenqi, Wu, Qun, Zhu, Jing, Pan, Baishen, Wang, Beili, Guo, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290220/ https://www.ncbi.nlm.nih.gov/pubmed/37161617 http://dx.doi.org/10.1002/jcla.24890

Ejemplares similares

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

MON-593 Thyrotropin Receptor Stimulating Immunoglobulin: Clinical Utility in Graves' Disease Diagnosis
por: Marques, Bernardo, et al.
Publicado: (2019)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
por: Khamisi, Selwan, et al.
Publicado: (2023)

Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah
por: Radhi, Maher A, et al.
Publicado: (2023)

Elevated Graves’ Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis
por: Alvin Mathew, Anu, et al.
Publicado: (2021)

Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
por: Cho, Won Yong, et al.
Publicado: (1988)

Painless Thyroiditis with Thyrotropin Receptor-blocking and Receptor-stimulating Autoantibodies
por: Kamijo, Keiichi
Publicado: (2019)

Estradiol Affects Epstein–Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves’ Disease Patients and Healthy Controls
por: Hara, Sayuri, et al.
Publicado: (2018)

Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990)

SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease
por: Zhou, Yulin, et al.
Publicado: (2021)

Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
por: Cho, B. Y., et al.
Publicado: (1993)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Thyrotropin Receptor Blocking Antibodies
por: Diana, Tanja, et al.
Publicado: (2018)

SAT-557 Functional Thyrotropin Receptor Antibodies Confirm a Novel Graves' Disease Animal Model
por: Diana, Tanja, et al.
Publicado: (2019)

Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
por: Sarić-Matutinović, Marija, et al.
Publicado: (2022)

Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment
por: Tsukada, Daichi, et al.
Publicado: (2022)

Association of clinical course with thyroid-stimulating immunoglobulin in Graves’ ophthalmopathy in Mongolians
por: Bayarmunkh, Oyungerel, et al.
Publicado: (2022)

Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction
por: Cui, Yiwen, et al.
Publicado: (2019)

Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease
por: Kim, Jinyoung, et al.
Publicado: (2021)

MON-583 Functional Thyrotropin Receptor Antibodies in Pregnant Women with Thyroid Autoimmunity
por: Diana, Tanja, et al.
Publicado: (2019)

Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity
por: Song, Young Shin, et al.
Publicado: (2016)

The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease
por: Baek, Han-Sang, et al.
Publicado: (2022)

Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease
por: Sherfan, Julie, et al.
Publicado: (2023)

Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
por: Silvestre, Ramona A., et al.
Publicado: (2021)

Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid‐stimulating receptor antibody in the diagnosis of Graves’ disease
por: Hu, Yao, et al.
Publicado: (2021)

Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves’ disease patients and in healthy individuals
por: Nagata, Keiko, et al.
Publicado: (2014)

An Interesting Case of Euthyroid Graves’ Ophthalmopathy, With Negative Thyroid-Stimulating Hormone Receptor Antibodies
por: Moeen, Zunera, et al.
Publicado: (2021)

Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
por: Park, Jungyul, et al.
Publicado: (2023)

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
por: Pearce, Simon H.S., et al.
Publicado: (2019)

Antibodies against thyroid-stimulating hormone receptor cause maternal-neonatal transmission of Graves' Disease
por: Yu, Yue, et al.
Publicado: (2021)

Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.
por: van der Kallen, C. J., et al.
Publicado: (1996)

SAT-422 Evaluation of the Siemens Thyroid Stimulating Immunoglobulin (TSI) Assay for Diagnosis and Prognosis of Graves’ Disease
por: Paul, Heather, et al.
Publicado: (2020)

Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production
por: Ke, Sujie, et al.
Publicado: (2021)

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA
por: Zhao, Shuang-Xia, et al.
Publicado: (2011)

ELF3-induced miR-182 inhibits adipogenic differentiation in Graves’ orbitopathy by targeting thyrotropin receptor
por: Wang, Sha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_far8n7l5j1c8jn1eie9hn97drg